Preclinical characterization of the anti-tumor activity of the investigational anti-B7-H3 antibody-drug conjugate (ADC), vobramitamab duocarmazine (vobra duo), in pediatric sarcomas (pSC)

vobramitamab duocarmazine (MGC018) - MacroGenics

https://www.abstractsonline.com/pp8/#!/20273/presentation/7927

Giovanna Bianchi; Gaia Rolandi; Fabio Pastorino; Daniela Segalerba; Nicoletta Pedemonte; Valeria Tomati; Eleonora Ciampi; Mirco Ponzoni; Chiara Brignole

Mar 26, 2025